Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19 - The Lancet Neurology
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
Brain MRI of the patients with MOG antibody-associated disease. (A and... | Download Scientific Diagram
MOGAD Awareness Month (1) | spinal cord, inflammation | We begin MOG Antibody Disease Awareness Month by giving a short description and explanation of MOG antibody disease. MOG antibody disease, or MOGAD, is a... | By Siegel Rare Neuroimmune ...
MOG antibody demyelination | Great Ormond Street Hospital
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
MOG Antibodies Tied to More Pediatric Conditions | MedPage Today
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Myelitis Presenting with Headache | Canadian Journal of Neurological Sciences | Cambridge Core